Intracavitary prophylactic treatment with interferon alpha 2b of patients with superficial bladder cancer is associated with a systemic T-cell activation

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.

Elizabeth A. Grimm, A Mazumder, H Z Zhang et al. · The Journal of Experimental Medicine · 1982 · 2.2K citations · Full text

Life Sciences, Immunology, Oncology +15

Intracavitary Bacillus Calmette-guerin in the Treatment of Superficial Bladder Tumors

Álvaro Morales, David Eidinger, Andrew W. Bruce · The Journal of Urology · 1976 · 1.8K citations

Medicine, Oncology, Urology +5

Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth.

John H. Kehrl, Lalage M. Wakefield, Anita B. Roberts et al. · The Journal of Experimental Medicine · 1986 · 1.6K citations · Full text

Life Sciences, Cell Biology, Immunology +15

Intracavitary Bacillus Calmette-Guerin in the Treatment of Superficial Bladder Tumors

Álvaro Morales, David Eidinger, Andrew W. Bruce · The Journal of Urology · 2016 · 1.5K citations

Medicine, Oncology, Urology +5

Contingent Genetic Regulatory Events in T Lymphocyte Activation

Gerald R. Crabtree · Science · 1989 · 1.1K citations

Life Sciences, Genetics, Immunology +16